Literature DB >> 26280659

The imagined itch: brain circuitry supporting nocebo-induced itch in atopic dermatitis patients.

V Napadow1,2, A Li1, M L Loggia1, J Kim1, I Mawla1, G Desbordes1, P C Schalock3, E A Lerner3, T N Tran3, J Ring4, B R Rosen1, T J Kaptchuk5, F Pfab1,4,6.   

Abstract

BACKGROUND: Psychological factors are known to significantly modulate itch in patients suffering from chronic itch. Itch is also highly susceptible to both placebo and nocebo (negative placebo) effects. Brain activity likely supports nocebo-induced itch, but is currently unknown. <br> METHODS: We collected functional MRI (fMRI) data from atopic dermatitis (AD) patients, in a within-subject design, and contrast brain response to nocebo saline understood to be allergen vs open-label saline control. Exploratory analyses compared results to real allergen itch response and placebo responsiveness, evaluated in the same patients. <br> RESULTS: Nocebo saline produced greater itch than open saline control (P < 0.01). Compared to open saline, nocebo saline demonstrated greater fMRI response in caudate, dorsolateral prefrontal cortex (dlPFC), and intraparietal sulcus (iPS) - brain regions important for cognitive executive and motivational processing. Exploratory analyses found that subjects with greater dlPFC and caudate activation to nocebo-induced itch also demonstrated greater dlPFC and caudate activation, respectively, for real allergen itch. Subjects reporting greater nocebo-induced itch also demonstrated greater placebo reduction of allergen-evoked itch, suggesting increased generalized modulation of itch perception. <br> CONCLUSIONS: Our study demonstrates the capacity of nocebo saline to mimic both the sensory and neural effects of real allergens and provides an insight to the brain mechanisms supporting nocebo-induced itch in AD, thus aiding our understanding of the role that expectations and other psychological factors play in modulating itch perception in chronic itch patients.
© 2015 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  atopic dermatitis; caudate; nocebo; placebo; pruritus

Mesh:

Substances:

Year:  2015        PMID: 26280659      PMCID: PMC4609272          DOI: 10.1111/all.12727

Source DB:  PubMed          Journal:  Allergy        ISSN: 0105-4538            Impact factor:   13.146


  42 in total

1.  Getting the pain you expect: mechanisms of placebo, nocebo and reappraisal effects in humans.

Authors:  Irene Tracey
Journal:  Nat Med       Date:  2010-10-14       Impact factor: 53.440

2.  Anterior intraparietal sulcus is sensitive to bottom-up attention driven by stimulus salience.

Authors:  Joy J Geng; George R Mangun
Journal:  J Cogn Neurosci       Date:  2009-08       Impact factor: 3.225

3.  Effect of acupuncture on allergen-induced basophil activation in patients with atopic eczema:a pilot trial.

Authors:  Florian Pfab; Georgios I Athanasiadis; Johannes Huss-Marp; Jiang Fuqin; Beate Heuser; Liliana Cifuentes; Knut Brockow; Wolfgang Schober; Alexander Konstantinow; Dominik Irnich; Heidrun Behrendt; Johannes Ring; Markus Ollert
Journal:  J Altern Complement Med       Date:  2011-03-28       Impact factor: 2.579

4.  Contagious itch in humans: a study of visual 'transmission' of itch in atopic dermatitis and healthy subjects.

Authors:  A D P Papoiu; H Wang; R C Coghill; Y-H Chan; G Yosipovitch
Journal:  Br J Dermatol       Date:  2011-05-17       Impact factor: 9.302

5.  Influence of acupuncture on type I hypersensitivity itch and the wheal and flare response in adults with atopic eczema - a blinded, randomized, placebo-controlled, crossover trial.

Authors:  F Pfab; J Huss-Marp; A Gatti; J Fuqin; G I Athanasiadis; D Irnich; U Raap; W Schober; H Behrendt; J Ring; U Darsow
Journal:  Allergy       Date:  2009-12-11       Impact factor: 13.146

Review 6.  Neurocircuitry of addiction.

Authors:  George F Koob; Nora D Volkow
Journal:  Neuropsychopharmacology       Date:  2010-01       Impact factor: 7.853

7.  Accurate and robust brain image alignment using boundary-based registration.

Authors:  Douglas N Greve; Bruce Fischl
Journal:  Neuroimage       Date:  2009-06-30       Impact factor: 6.556

8.  Temperature modulated histamine-itch in lesional and nonlesional skin in atopic eczema - a combined psychophysical and neuroimaging study.

Authors:  F Pfab; M Valet; T Sprenger; J Huss-Marp; G I Athanasiadis; H J Baurecht; A Konstantinow; C Zimmer; H Behrendt; J Ring; T R Tölle; U Darsow
Journal:  Allergy       Date:  2009-10-05       Impact factor: 13.146

9.  The effect of treatment expectation on drug efficacy: imaging the analgesic benefit of the opioid remifentanil.

Authors:  Ulrike Bingel; Vishvarani Wanigasekera; Katja Wiech; Roisin Ni Mhuircheartaigh; Michael C Lee; Markus Ploner; Irene Tracey
Journal:  Sci Transl Med       Date:  2011-02-16       Impact factor: 17.956

10.  How the number of learning trials affects placebo and nocebo responses.

Authors:  Luana Colloca; Predrag Petrovic; Tor D Wager; Martin Ingvar; Fabrizio Benedetti
Journal:  Pain       Date:  2010-11       Impact factor: 7.926

View more
  17 in total

Review 1.  [Psychological aspects of pruritus and therapy options].

Authors:  A Stumpf; C Schut; G Schneider
Journal:  Hautarzt       Date:  2016-08       Impact factor: 0.751

Review 2.  [The effect of treatment expectations on pruritus and skin pain].

Authors:  F Krefting; S Hölsken; M Schedlowski; W Sondermann
Journal:  Schmerz       Date:  2021-10-27       Impact factor: 1.629

3.  Nocebo Effects on Cowhage-evoked Itch: A Randomized Controlled Trial of Classical Conditioning and Observational Learning.

Authors:  Joseph S Blythe; Kaya J Peerdeman; Dieuwke S Veldhuijzen; Myrthe M E van Schothorst; Mia A Thomaïdou; Antoinette I M van Laarhoven; Andrea W M Evers
Journal:  Acta Derm Venereol       Date:  2021-01-13       Impact factor: 3.875

4.  Minimizing nocebo effects by conditioning with verbal suggestion: A randomized clinical trial in healthy humans.

Authors:  Danielle J P Bartels; Antoinette I M van Laarhoven; Michiel Stroo; Kim Hijne; Kaya J Peerdeman; A Rogier T Donders; Peter C M van de Kerkhof; Andrea W M Evers
Journal:  PLoS One       Date:  2017-09-14       Impact factor: 3.240

5.  Emotion-specific nocebo effects: an fMRI study.

Authors:  Anne Schienle; Carina Höfler; Sonja Übel; Albert Wabnegger
Journal:  Brain Imaging Behav       Date:  2018-02       Impact factor: 3.978

6.  Non-pharmacological Effects in Switching Medication: The Nocebo Effect in Switching from Originator to Biosimilar Agent.

Authors:  Lars Erik Kristensen; Rieke Alten; Luis Puig; Sandra Philipp; Tore K Kvien; Maria Antonia Mangues; Frank van den Hoogen; Karel Pavelka; Arnold G Vulto
Journal:  BioDrugs       Date:  2018-10       Impact factor: 5.807

7.  Using the placebo effect: how expectations and learned immune function can optimize dermatological treatments.

Authors:  Andrea W M Evers
Journal:  Exp Dermatol       Date:  2017-01       Impact factor: 3.960

Review 8.  The Clinical Implications of Nocebo Effects for Biosimilar Therapy.

Authors:  Luana Colloca; Remo Panaccione; T Kevin Murphy
Journal:  Front Pharmacol       Date:  2019-11-29       Impact factor: 5.810

9.  Incidence of Placebo Adverse Events in Randomized Clinical Trials of Targeted and Immunotherapy Cancer Drugs in the Adjuvant Setting: A Systematic Review and Meta-analysis.

Authors:  Matías Rodrigo Chacón; Diego Hernán Enrico; Jeannette Burton; Federico Daniel Waisberg; Viviana Marina Videla
Journal:  JAMA Netw Open       Date:  2018-12-07

10.  Single-use IgE-selective immunoadsorber column for the treatment of severe atopic dermatitis.

Authors:  Damian Meyersburg; Martin Laimer; Andrea Kugler; Eva Mühlthaler; Nadja Lindlbauer; Wolfgang Hitzl; Eva Rohde; Johann W Bauer; Christoph Grabmer
Journal:  J Clin Apher       Date:  2019-11-22       Impact factor: 2.821

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.